Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

The Role of STAT5 in HOXA9-Associated Leukemia

Peilin Ma, MD, PhD, Yuqing Sun, MS, Jingya Wang, PhD, Weihua Song, MD, PhD, Tao Xu, PhD, Reuben Kapur, PhD, Jay L. Hess, MD PhD

Blood (2016) 128 (22): 3919.

https://doi.org/10.1182/blood.V128.22.3919.3919

Published: 2016

Journal Articles

Pathways Relevant to AML Pathogenesis Targeting the Hematopoietic-Specific Cebpa +37 Kb Enhancer

Stacy Cooper, MD, Hong Guo, MD PhD, Justin Thomas, Jay L. Hess, MD PhD, Peter D. Aplan, MD, Donald Small, MD PhD, Alan D. Friedman, MD

Blood (2016) 128 (22): 2691.

https://doi.org/10.1182/blood.V128.22.2691.2691

Published: 2016

Journal Articles

The same site on the integrase-binding domain of lens epithelium–derived growth factor is a therapeutic target for MLL leukemia and HIV

Marcelo J. Murai, Jonathan Pollock, Shihan He, Hongzhi Miao, Trupta Purohit, Adam Yokom, Jay L. Hess, Andrew G. Muntean, Jolanta Grembecka, Tomasz Cierpicki

Blood (2014) 124 (25): 3730–3737.

https://doi.org/10.1182/blood-2014-01-550079

Published: 2014

Includes: Supplemental data

Journal Articles

Characterization of the Molecular Interplay Between HOXA9 and Ogt in Leukemia

Jean-Francois M Rual, PhD, Tao Xu, PhD, Cailin Collins, Honglai Zhang, PhD, Jingya Wang, Rork Kuick, MS, Joel Bronstein, Venkatesha Basrur, PhD, Sung Soo Park, PhD, Kim Ha, Lili Chen, Kojo S.J. Elenitoba-Johnson, MD, Andrew G. Muntean, PhD, Jay L. Hess, MD PhD

Blood (2014) 124 (21): 3533.

https://doi.org/10.1182/blood.V124.21.3533.3533

Published: 2014

Journal Articles

The O-Linked N-Acetylglucosamine Transferase Modifies HOXA9 and Inhibits HOXA9-Driven Immortalization

Jean-Francois M Rual, PhD, Jay L. Hess, MD, PhD, MHSA, Tao Xu, PhD, Cailin Collins, Honglai Zhang, PhD, Kimberly Ha, Sung Soo Park, PhD, Joel Bronstein, Jingya Wang

Blood (2013) 122 (21): 4901.

https://doi.org/10.1182/blood.V122.21.4901.4901

Published: 2013

Journal Articles

MLL fusion protein–driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction

Andrew G. Muntean, Wei Chen, Morgan Jones, Eric M. Granowicz, Ivan Maillard, Jay L. Hess

Blood (2013) 122 (11): 1914–1922.

https://doi.org/10.1182/blood-2013-02-486977

Published: 2013

Includes: Supplemental data

Journal Articles

Mechanisms of Transcriptional Regulation and Transformation by HOXA9

Jay L. Hess, MD, PhD, Cailin Collins, Joel Bronstein, Yuqing Sun, Surya Nagaraja

Blood (2012) 120 (21): SCI-30.

https://doi.org/10.1182/blood.V120.21.SCI-30.SCI-30

Published: 2012

Journal Articles

C/ebpα and Pu.1 Are Members of a Critical Regulatory Network Required for Hoxa9-Mediated Immortalization

Cailin Collins, Jingya Wang, Joel Bronstein, Jay L. Hess, MD, PhD

Blood (2012) 120 (21): 650.

https://doi.org/10.1182/blood.V120.21.650.650

Published: 2012

Journal Articles

ECS ASB2 mediates MLL degradation during hematopoietic differentiation

Jingya Wang, Andrew G. Muntean, Jay L. Hess

Blood (2012) 119 (5): 1151–1161.

https://doi.org/10.1182/blood-2011-06-362079

Published: 2012

Includes: Supplemental data

Journal Articles

Identification and characterization of Hoxa9 binding sites in hematopoietic cells

Yongsheng Huang, Kajal Sitwala, Joel Bronstein, Daniel Sanders, Monisha Dandekar, Cailin Collins, Gordon Robertson, James MacDonald, Timothee Cezard, Misha Bilenky, Nina Thiessen, Yongjun Zhao, Thomas Zeng, Martin Hirst, Alfred Hero, Steven Jones, Jay L. Hess

Blood (2012) 119 (2): 388–398.

https://doi.org/10.1182/blood-2011-03-341081

Published: 2012

Includes: Supplemental data

Journal Articles

MLL Fusion Protein Driven AML Is Selectively Inhibited by Targeted Disruption of the MLL-PAFc Interaction

Andrew G. Muntean, PhD, Eric M Granowicz, Jay L. Hess, MD, PhD

Blood (2011) 118 (21): 56.

https://doi.org/10.1182/blood.V118.21.56.56

Published: 2011

Journal Articles

MLL-ENL Inhibits Polycomb Repressive Complex 1 to Achieve Efficient Transformation of Hematopoietic Cells

Emanuel Maethner, Constanze Breitinger, Maria-Paz Garcia-Cuellar, Ph.D., Jay L. Hess, MD, PhD, Robert K. Slany, PhD

Blood (2011) 118 (21): 2443.

https://doi.org/10.1182/blood.V118.21.2443.2443

Published: 2011

Journal Articles

Targeting Menin-MLL Interaction to Inhibit MLL Fusion Oncoproteins in Leukemia

Jolanta Grembecka, PhD, Shihan He, PhD, Aibin Shi, PhD, Trupta Purohit, Andrew G. Muntean, PhD, Xiaoqin Li, Thomas Hartley, Duxin Sun, PhD, Jay L. Hess, MD, PhD, Tomasz Cierpicki, PhD

Blood (2011) 118 (21): 2497.

https://doi.org/10.1182/blood.V118.21.2497.2497

Published: 2011

Journal Articles

Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation

Stephanie Y. Jo, Eric M. Granowicz, Ivan Maillard, Dafydd Thomas, Jay L. Hess

Blood (2011) 117 (18): 4759–4768.

https://doi.org/10.1182/blood-2010-12-327668

Published: 2011

Includes: Supplemental data

Journal Articles

A Novel Ubiquitination Pathway Regulates MLL Activity During Hematopoietic Differentiation

Jingya Wang, Ph.D., Andrew G. Muntean, PhD, Jay L. Hess, MD, PhD

Blood (2010) 116 (21): 743.

https://doi.org/10.1182/blood.V116.21.743.743

Published: 2010

Journal Articles

Assessment of DOT1L as a Therapeutic Target In Acute Leukemia

Stephanie Y Jo, Eric M Granowicz, Jay L. Hess, MD, PhD

Blood (2010) 116 (21): 3291.

https://doi.org/10.1182/blood.V116.21.3291.3291

Published: 2010

Journal Articles

CBX8, a Polycomb-Group Protein, Is Essential for MLL-AF9-Induced Leukemogenesis

Jiaying Tan, Jay L. Hess, MD, PhD

Blood (2010) 116 (21): 4174.

https://doi.org/10.1182/blood.V116.21.4174.4174

Published: 2010

Journal Articles

Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia

Cynthia L. Fisher, Nicolas Pineault, Christy Brookes, Cheryl D. Helgason, Hideaki Ohta, Caroline Bodner, Jay L. Hess, R. Keith Humphries, Hugh W. Brock

Blood (2010) 115 (1): 38–46.

https://doi.org/10.1182/blood-2009-07-230698

Published: 2010

Includes: Supplemental data

Journal Articles

The PHD fingers of MLL block MLL fusion protein–mediated transformation

Andrew G. Muntean, Diane Giannola, Aaron M. Udager, Jay L. Hess

Blood (2008) 112 (12): 4690–4693.

https://doi.org/10.1182/blood-2008-01-134056

Published: 2008

Includes: Supplemental data

Journal Articles

A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification

Dorothee Mueller, Christian Bach, Deniz Zeisig, Maria-Paz Garcia-Cuellar, Sara Monroe, Arun Sreekumar, Rong Zhou, Alexey Nesvizhskii, Arul Chinnaiyan, Jay L. Hess, Robert K. Slany

Blood (2007) 110 (13): 4445–4454.

https://doi.org/10.1182/blood-2007-05-090514

Published: 2007

NARROW

The Role of STAT5 in HOXA9-Associated Leukemia

Pathways Relevant to AML Pathogenesis Targeting the Hematopoietic-Specific Cebpa +37 Kb Enhancer

The same site on the integrase-binding domain of lens epithelium–derived growth factor is a therapeutic target for MLL leukemia and HIV

Characterization of the Molecular Interplay Between HOXA9 and Ogt in Leukemia

The O-Linked N-Acetylglucosamine Transferase Modifies HOXA9 and Inhibits HOXA9-Driven Immortalization

MLL fusion protein–driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction

Mechanisms of Transcriptional Regulation and Transformation by HOXA9

C/ebpα and Pu.1 Are Members of a Critical Regulatory Network Required for Hoxa9-Mediated Immortalization

ECS ASB2 mediates MLL degradation during hematopoietic differentiation

Identification and characterization of Hoxa9 binding sites in hematopoietic cells

MLL Fusion Protein Driven AML Is Selectively Inhibited by Targeted Disruption of the MLL-PAFc Interaction

MLL-ENL Inhibits Polycomb Repressive Complex 1 to Achieve Efficient Transformation of Hematopoietic Cells

Targeting Menin-MLL Interaction to Inhibit MLL Fusion Oncoproteins in Leukemia

Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation

A Novel Ubiquitination Pathway Regulates MLL Activity During Hematopoietic Differentiation

Assessment of DOT1L as a Therapeutic Target In Acute Leukemia

CBX8, a Polycomb-Group Protein, Is Essential for MLL-AF9-Induced Leukemogenesis

Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia

The PHD fingers of MLL block MLL fusion protein–mediated transformation

A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only